Immune check-point in cervical cancer

Cervical cancer (CC) is still one of the most commonly diagnosed cancer and one of the mainly leading cause of cancer death in female population (Siegel et al., 2017). Surgery, radiation therapy, chemotherapy or a combination of these therapeutic modalities represent the classical options to CC management (Anon, 2018; Marchetti et al., 2017). The appropriate strategy is based on tumor stage at diagnosis, but it remains dismal to improve survival in locally advanced or recurrent/metastatic disease (Pfaendler and Tewari, 2016).
Source: Critical Reviews in Oncology Hematology - Category: Cancer & Oncology Authors: Source Type: research